Evidence map›Paper›PMID 26910835›Full record

ArticleOncotarget2016

14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.

Yufu Tang, Shupeng Liu, Nan Li, Weixing Guo, Jie Shi, Hongming Yu, Long Zhang, Kang Wang, Shangrong Liu, Shuqun Cheng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The mechanobiome: a goldmine for cancer therapeutics.American journal of physiology. Cell physiology · 2021
    Review
  11. Article
  12. Expression ofOncology letters · 2020
    Article
  13. Overexpression of 14-3-3BioMed research international · 2020
    Article
  14. Review
  15. 14-3-3ζ binds to and stabilizes phospho-beclin 1Journal of cellular and molecular medicine · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yufu TangEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Shupeng LiuChanghai Hospital, Second Military Medical University, Shanghai 200433, China.
Nan LiEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Weixing GuoEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Jie ShiEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Hongming YuEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Long ZhangEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Kang WangEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Shangrong LiuChanghai Hospital, Second Military Medical University, Shanghai 200433, China.
Shuqun ChengEastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Eastern Hepatobiliary Surgery Hospital · CNSecond Military Medical University · CNChanghai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal vein tumor thrombus (PVTT) is a type of intrahepatic metastasis arising from hepatocellular carcinoma (HCC) and is highly correlated with a poor prognosis. Hypoxia is common in solider tumors, including HCC, where it alters the behavior of HCC cells. We asked whether and how hypoxia contributes to PVTT formation. We demonstrated that increased intratumoral hypoxia is strongly associated with PVTT formation in HCC. We also showed that 14-3-3ζ is induced by hypoxia in HCC cells and correlates with PVTT formation in clinical HCC samples. In addition, 14-3-3ζ up-regulates HIF-1α expression by recruiting HDAC4, which prevents HIF-1α acetylation, thereby stabilizing the protein. Under hypoxic conditions in vitro, 14-3-3ζ knockdown inhibits hypoxia-induced HCC invasion by the HIF-1α/EMT pathway. Blockade of 14-3-3ζ in HCC cells reduces PVTT formation and distant lung metastasis in vivo. Moreover, a combination of 14-3-3ζ and HIF-1α expression is more prognostic for HCC patients than either protein alone. These results suggest that the hypoxia/14-3-3ζ/HIF-1α pathway plays an important role in PVTT formation and HCC metastasis.

Indexed as

14-3-3 ProteinsCarcinoma, HepatocellularHumansHypoxia-Inducible Factor 1, alpha SubunitLiver NeoplasmsNeoplasm InvasivenessPortal VeinPrognosis14-3-3 ProteinsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitYWHAZ protein, humanhepatocellular carcinomahypoxiametastasisportal vein tumor thrombus

Identifiers

PMID26910835
PMCPMC4941282
OpenAlexW2288781552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.